Radiance Biopharma
Boston, US · Founded 2023 · Delaware corporation
Founders & leadership
RB
Robert BrooksNamed on SEC filing
ML
Marc LippmanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2024
▶$250KraisedFeb 2024 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedFeb 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert BrooksExecutive Officer, Director
- Marc LippmanExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $250K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Radiance Biopharma raised?
- Radiance Biopharma has disclosed $250K raised across 1 round.
- Where is Radiance Biopharma headquartered?
- Radiance Biopharma is headquartered in Boston, US.